Navigation Links
Discovery Labs Reports Third Quarter 2012 Financial Results
Date:11/8/2012

nts have been classified as derivative liabilities in accordance with generally accepted accounting principles because they do not expressly state that there is no circumstance in which the Company will be required to settle the warrants in cash.Readers are referred to, and encouraged to read in their entirety, the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 to be filed with the Securities and Exchange Commission, which includes further detail on the above-referenced transactions and the Company's business plans and operations, financial condition and results of operations.

ABOUT DISCOVERY LABS
Discovery Laboratories, Inc. is a specialty biotechnology company with one focus – to advance a new standard in respiratory critical care.  Discovery Labs' novel proprietary KL4 surfactant technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, lyophilized, and aerosolized dosage forms. Discovery Labs is also developing its proprietary drug delivery technologies to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs believes that its proprietary technologies make it possible, for the first time, to develop a significant pipeline of products to address a variety of respiratory diseases for which there frequently are few or no approved therapies.  For more information, please visit our website at www.Discoverylabs.com.

Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, all such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements are subject to certain risks and uncertainties that could cause actual results, in
'/>"/>

SOURCE Discovery Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. TeraDiscoveries to Use its Inverse Design Software Running on Windows Azure to Advance Its Computational Drug Discovery Process
2. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
3. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
4. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
5. Dr. Paul Karila Appointed Head of Discovery Services at Cellectricon AB
6. Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
7. Drug Discovery Technologies Market Soars to $79 billion by 2017, Driven by Innovations in Pipeline and Tools Development
8. AMRI Further Expands Discovery Capabilities in India
9. Tetra Discovery Partners Receives Major NIH Award To Develop New Alzheimers Drug
10. Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession
11. Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Pulse Systems, Inc. , an ... Practice Management , and Revenue Cycle Management (RCM) solutions ... performed by some RCM vendors, at UBM Medica,s Practice ... on September 19-20, 2014.  A presenter at ... September with a new session encouraging practices to "Look before ...
(Date:8/27/2014)... An experimental drug designed to help regulate the ... for anemia of inflammation, according to results from the first ... in Blood , the Journal of the ... Anemia is a condition that occurs when red blood cells ... an individual has anemia, the body does not get enough ...
(Date:8/27/2014)... STATESVILLE, N.C. , Aug. 27, 2014 ... today its Board of Directors increased its quarterly cash ... from eleven cents per outstanding share, beginning with the ... record at the close of business on September 8, ... Founded in 1906, Kewaunee Scientific Corporation is ...
Breaking Medicine Technology:Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3
... 2011 The Specialty Pharma Association announces its Fall Conference - ... 2011, San Diego Marriott Marquis Hotel & Marina ... Robert Greenwood, RPh President National ... PgMP, TSPM, ITBMC President TenStep, Inc. ...
... N.J. and PHILADELPHIA, Aug. 22, 2011 Oncobiologics, ... an agreement to co-develop a novel, next-generation bi-specific ... solid tumors. The jointly engineered platform is designed ... promising cancer treatments. This research program is now ...
Cached Medicine Technology:Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform 2Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform 3
(Date:8/27/2014)... 2014 All Canada Goose Parkas ... go from classic to modern. With unique detailing such as ... them is a step up in opulence. Recently, the company ... Parkas for 2014. , True enough, the new ... great discounts (up to 28% off) on all these brand ...
(Date:8/27/2014)... Today, Zane Benefits, the #1 Online Health ... administering a premium reimbursement plan. , According to ... is top of mind for employers, health insurance brokers, ... and premium reimbursement, there are important compliance considerations to ... webinar, Zane Benefits President, Rick Lindquist, will cover three ...
(Date:8/27/2014)... Locating an approximate price for an insurance ... information before rates would be viewable. The Quotes Pros ... are distributed online using its policy locator at ... adult has access to review using the national finder ... for quotation distribution built in 2013 is now programmed ...
(Date:8/27/2014)... iFitDress.com, a professional company of women’s dresses and related ... bridal gowns . To top it all off, all ... percent off) when buying the company’s new items. ... with these new items. All its online sales representatives ... can gain an enjoyable shopping experience on its website. ...
(Date:8/27/2014)... Md. (PRWEB) August 27, 2014 ... recently released guidelines for the management and treatment ... Therapy for Pulmonary Arterial Hypertension in Adults: CHEST ... free to view for clinicians, and provide the ... , The Pulmonary Hypertension Association (PHA) ...
Breaking Medicine News(10 mins):Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Life Insurance Quotes for Term Policies Now Found at Insurer Website Online 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2
... Oct. 8 Plexus Systems, Inc.,provider of ... today announced a set of enhancements for ... integrated program that will,provide enterprise-wide compliance with ... regulations mandated by the U.S. Food and ...
... LISBON, Portugal and NEW YORK, Oct. ... Hopkins University scientists the most prestigious,vision award ... combating blindness, the,Antonio Champalimaud Foundation continued its ... of its 300,000-square-foot research,facility. The Champalimaud Foundation ...
... be able to share information collected from many thousands of ... Australian National University in Canberra today. , The ANU node ... the John Curtin School of Medical Research, Garran Road, ANU ... to attend for a demonstration of the Grid and interviews. ...
... gaps exist between states, and between poor, middle- and ... News) -- For American children, the state they live ... determine how healthy they are, a new survey shows. ... are in less than optimal health, according to the ...
... service for its smartTOUCH(R),product line, JERICHO, N.Y., ... today announced that it has signed a three ... Mr.,Handyman, to provide its customers professional installation and,programming ... door openers, door locks, thermostats, mailboxes and more., ...
... Cleared for,Patients Who Have Not Benefited From Prior ... Neuronetics, Inc., a,privately-held medical device company and a ... the U.S. Food and Drug Administration,(FDA) has cleared ... the treatment of depression. NeuroStar TMS Therapy(R) is,specifically ...
Cached Medicine News:Health News:Plexus Online Enhances Functions for Medical Device Manufacturing Regulatory Compliance 2Health News:World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center 2Health News:World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center 3Health News:Medical data 'Internet' goes live, boosts research 2Health News:Family Income Impacts Children's Health 2Health News:Family Income Impacts Children's Health 3Health News:Family Income Impacts Children's Health 4Health News:Family Income Impacts Children's Health 5Health News:bioMETRX Teams Up With Mr. Handyman 2Health News:bioMETRX Teams Up With Mr. Handyman 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 2Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 4Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 5
... Captia Borrelia burgdorferi (B. burgdorferi) IgG/IgM Enzyme ... the qualitative presumptive (firststep) detection of total ... serum. This ELISA should only be used ... are consistent with Lyme disease. Equivocal or ...
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
SURGIPRO™ BLUE Monofilament Suture in two sizes....
Surgitie&trade Single Use Ligating Loops with Delivery System...
Medicine Products: